# Bioequivalence Study of Idalopirdine Tablets 60 mg

> **NCT02371707** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Idalopirdine 60 mg formulation A (test)
- **DRUG:** Idalopirdine 60 mg formulation B (reference)

## Key facts

- **NCT ID:** NCT02371707
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371707, "Bioequivalence Study of Idalopirdine Tablets 60 mg". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02371707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*